Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Dividend Declaration

31 Oct 2018 07:00

RNS Number : 7848F
Natwest Markets PLC
31 October 2018
 

 

 

Royal Bank of Scotland Group

 

31st October 2018

 

NatWest Markets Plc Declaration of Interim Dividend

 

NatWest Markets Plc (NatWest Markets) today announces it has declared an interim ordinary dividend payable to its parent company, The Royal Bank of Scotland Group plc (RBSG Group), of 575.70 pence per ordinary share, corresponding to a total payment of £2.3 billion.

 

On a pro forma basis, the dividend reduces NatWest Markets' Common Equity Tier 1 (CET1) ratio as at 30 September 2018 by 5.6% from 22.7% to 17.1%, in line with the RBS Group's internal capital management plan. The dividend does not have any impact on the RBS Group's CET1 ratio.

 

For further information contact:

 

NatWest Markets Investor Relations

Richard Coombs

Head of NatWest Markets Investor Relations

+44 (0) 20 7678 2069

 

RBS Investor Relations:

Matt Waymark

Head of Investor Relations

+44 (0) 20 7672 1758 

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, and requirements, financial position, future pension funding requirements, on-going litigation and regulatory investigations, profitability, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "believes", "risk", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

 

 

Legal Entity Identifiers

 

NatWest Markets Plc

 

RR3QWICWWIPCS8A4S074

The Royal Bank of Scotland Group plc

 

2138005O9XJIJN4JPN90

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVEAFEEDSSPFAF
Date   Source Headline
9th Apr 20146:15 pmRNSDAS - Revised State Aid Terms
8th Apr 20144:20 pmRNSBlock Listing Return
8th Apr 20144:06 pmRNSDirector/PDMR Shareholding
4th Apr 20147:00 amRNSDirectorate Change
2nd Apr 201412:55 pmRNSHolding(s) in Company
31st Mar 20145:29 pmRNSTotal Voting Rights
28th Mar 20149:39 amRNSRBSG SEC Registered Senior Notes Transaction
26th Mar 20146:19 pmRNSStabilisation Notice
25th Mar 20148:46 amRNSMorgan Stanley European Financials Conference
24th Mar 20143:53 pmRNSPublication of Final Terms
19th Mar 20141:49 pmRNSPublication of Prospectus
10th Mar 20145:51 pmRNSPublication of Prospectus
10th Mar 20144:51 pmRNSDirector/PDMR Shareholding
7th Mar 20146:24 pmRNSPublication of Registration Document
7th Mar 20141:10 pmRNSDirectorate Change
7th Mar 20141:00 pmRNSDirector/PDMR Shareholding
7th Mar 20141:00 pmRNSInvestor Meeting
28th Feb 20145:26 pmRNSTotal Voting Rights
28th Feb 20143:30 pmRNSDirector/PDMR Shareholding
28th Feb 201412:30 pmRNSAdditional Listing
27th Feb 20147:03 amRNSCompletion of Sale of Remaining Interest in DLG
27th Feb 20147:01 amRNSDirectorate Change
27th Feb 20147:01 amRNSFinal Results - Part 6 of 6
27th Feb 20147:01 amRNSFinal Results - Part 5 of 6
27th Feb 20147:01 amRNSFinal Results - Part 4 of 6
27th Feb 20147:01 amRNSFinal Results - Part 3 of 6
27th Feb 20147:01 amRNSFinal Results - Part 2 of 6
27th Feb 20147:00 amRNSFinal Results - Part 1 of 6
26th Feb 20144:57 pmRNSIntention to Sell Remaining Interest in DLG
21st Feb 20144:14 pmRNSDividend Declaration
19th Feb 20149:00 amRNSRBS Structured Retail IP&ED Business
10th Feb 201410:35 amRNSDirector/PDMR Shareholding
3rd Feb 20145:19 pmRNSCorrection: Total Voting Rights
31st Jan 20144:24 pmRNSHolding(s) in Company
31st Jan 20143:24 pmRNSTotal Voting Rights
27th Jan 20144:06 pmRNSTrading Update
16th Jan 20145:00 pmRNSHolding(s) in Company
15th Jan 201412:47 pmRNSRBS AND RBS NV ANNOUNCE CASH TENDER OFFER RESULTS
9th Jan 20141:30 pmRNSNotification of Major Interest in Shares
8th Jan 20149:13 amRNSDirector/PDMR Shareholding
7th Jan 20142:04 pmRNSSale of selected Chicago-area operations
31st Dec 201312:36 pmRNSTotal Voting Rights
31st Dec 201312:30 pmRNSDirector/PDMR Shareholding
19th Dec 20134:59 pmRNSPublication of Prospectus
17th Dec 201310:54 amRNSRBSG announces $2 billion T2 Notes transaction
16th Dec 20136:24 pmRNSEU-wide EBA Transparency Exercise
16th Dec 20135:07 pmRNSRBS cancels contingent capital facility with HMT
11th Dec 20136:13 pmRNSRBS Reaches Settlement Regarding OFAC Compliance
11th Dec 20137:00 amRNSRBS confirms Nathan Bostock to resign
9th Dec 20136:20 pmRNSALLOTMENT AND ISSUE OF NEW ORDINARY SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.